May 15, 2026 07:00AM
Dec 9, 2025 07:01AM
Dec 9, 2025 07:00AM
Nov 14, 2025 07:00AM
Nov 14, 2025 07:00AM
Sep 22, 2025 07:00AM
Sep 22, 2025 07:00AM Satellos Announces IND Submission to the U.S. FDA and Global Regulatory Filings to Advance a Phase 2 Clinical Trial of SAT-3247 in Children with Duchenne Muscular Dystrophy
Aug 13, 2025 07:00AM
Nov 13, 2024 07:00AM
Aug 12, 2024 07:00AM
Aug 8, 2024 07:00AM
May 28, 2024 07:00AM
May 14, 2024 07:00AM
Mar 27, 2024 07:00AM Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights

324,307 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All